- Analysis of primary and secondary EGFR-TKI resistance mutations evolution in 835 EGFR-mutant Chinese lung cancers.Dong, Xiaorong; Zeng, Dongqiang; Liu, Xinyi; Huang, MengliAnnual Meeting of the American-Association-for-Cancer-Research (AACR), Philadelphia, PA, 2021-04-10 To 2021.
- KRAS G12 subtypes with co-mutated TP53, LRP1B, STK11, KEAP1 in lung cancer and their impact on TMB levels, PD-L1 expression and overall survivalZhao, Y.; Wu, X.; Tang, H.; Qi, Q.; Zhang, C.; Liu, X.; Huang, M.Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), ELECTR NETWORK, 2022-09-09 To 2022-09-13.
- Analysis of MET genetic aberrations in Chinese solid tumor patients.Huang, Guanglong; Bian, Zhengying; Ma, Juan; Chen, Siqi; Lu, Guanghua; Ding, Ran; Bu, FanfengAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 2022-06-03 To 2022-06-07.被引 1
会议论文
The distribution of genetic mutations correlated with resistance to KRASG12C inhibitors in Chinese patients with lung cancer.
16阅读
